Actinium Pharmaceuticals, Inc. (ATNM)
USD 1.16
(-4.92%)
USD 1.16
(-4.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -47.33 Million | 8.64 Million | -20.86 Million | -21.61 Million | -21.46 Million | -20.57 Million |
| Net Income | -48.81 Million | -33.01 Million | -24.77 Million | -22.21 Million | -21.89 Million | -23.65 Million |
| Depreciation & Amortization | 790 Thousand | 699 Thousand | 524 Thousand | 447 Thousand | 420.08 Thousand | 50.72 Thousand |
| Deferred income taxes | 2.17 Million | 401.99 Thousand | -1.54 Million | -2.4 Million | -3.39 Million | - |
| Stock-based compensation | 3.84 Million | 2.79 Million | 1.69 Million | 1.25 Million | 1.29 Million | 1.79 Million |
| Change in working capital | -3.14 Million | 38.16 Million | 1.69 Million | -1.1 Million | -1.27 Million | 1.23 Million |
| Other non-cash items | -2.17 Million | -401.99 Thousand | 1.54 Million | 2.4 Million | 3.39 Million | 766.59 Thousand |
| Investing Cash Flow | -153 Thousand | -366 Thousand | -133 Thousand | -253 Thousand | -63.89 Thousand | -96.09 Thousand |
| Investments in PPE | -153 Thousand | -366 Thousand | -133 Thousand | -253 Thousand | -63.89 Thousand | -96.09 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 14.87 Million | 23.1 Million | 35.22 Million | 76.17 Million | 17.11 Million | 16.98 Million |
| Debt repayment | -4000.00 | -49 Thousand | -85 Thousand | -460 Thousand | -73 Thousand | - |
| Dividends payments | - | - | - | -1000.00 | -1269.00 | - |
| Common Stock Repurchased | - | - | - | 1000.00 | - | - |
| Common Stock Issuance | 14.87 Million | 23.15 Million | 35.3 Million | 76.58 Million | 17.43 Million | 16.97 Million |
| Other Financing Activities | 262 Thousand | 23.1 Million | 6000.00 | 47 Thousand | 17.18 Million | 4849.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -2.17 Million | 4.59 Million | 1.19 Million | -257 Thousand | -1.25 Million | 1.13 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -972 Thousand | 33.57 Million | 495 Thousand | -846 Thousand | -21.45 Thousand | 100.03 Thousand |
| Cash at beginning of period | 109.3 Million | 78.22 Million | 63.99 Million | 9.69 Million | 14.1 Million | 17.79 Million |
| Cash at end of period | 76.67 Million | 109.6 Million | 78.22 Million | 63.99 Million | 9.69 Million | 14.1 Million |
| Capital Expenditure | -153 Thousand | -366 Thousand | -133 Thousand | -253 Thousand | -63.89 Thousand | -96.09 Thousand |
| Effect of forex changes on cash | -11 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -32.62 Million | 31.38 Million | 14.22 Million | 54.3 Million | -4.41 Million | -3.68 Million |
| Free Cash Flow | -47.48 Million | 8.27 Million | -20.99 Million | -21.87 Million | -21.52 Million | -20.66 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.35 Million | -8.67 Million | -48.81 Million | -9.32 Million | -13.27 Million | -15.18 Million |
| Depreciation & Amortization | 189 Thousand | 216 Thousand | 790 Thousand | 199 Thousand | 200 Thousand | 209 Thousand |
| Deferred income taxes | - | - | 2.17 Million | -1.52 Million | -1.8 Million | -142 Thousand |
| Stock-based compensation | 1.37 Million | 1.37 Million | 3.84 Million | 927 Thousand | 921 Thousand | 1 Million |
| Change in working capital | 1.81 Million | -298 Thousand | -3.14 Million | 708 Thousand | 1.03 Million | 328 Thousand |
| Other non-cash items | 88 Thousand | 2.25 Million | -2.17 Million | 1.52 Million | 1.8 Million | 142 Thousand |
| Investing Cash Flow | - | -11 Thousand | -153 Thousand | - | -30 Thousand | -47 Thousand |
| Investments in PPE | - | -11 Thousand | -153 Thousand | - | -30 Thousand | -47 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 9.95 Million | 14.76 Million | 14.87 Million | 1.19 Million | 2.86 Million | 10.04 Million |
| Debt repayment | -3000.00 | -2000.00 | -4000.00 | -1000.00 | -1000.00 | -1000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 9.95 Million | 14.77 Million | 14.87 Million | 1.19 Million | 2.86 Million | 9.78 Million |
| Other Financing Activities | 9.95 Million | 14.77 Million | 262 Thousand | 1.19 Million | 2.86 Million | 261 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.66 Million | -440 Thousand | -2.17 Million | -196 Thousand | -488 Thousand | 1.27 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 154 Thousand | 142 Thousand | -972 Thousand | 904 Thousand | 1.51 Million | -949 Thousand |
| Cash at beginning of period | 84.05 Million | 76.67 Million | 109.3 Million | 82.97 Million | 91.58 Million | 95.22 Million |
| Cash at end of period | 86.03 Million | 84.05 Million | 76.67 Million | 76.67 Million | 83.28 Million | 91.58 Million |
| Capital Expenditure | - | -11 Thousand | -153 Thousand | - | -30 Thousand | -47 Thousand |
| Effect of forex changes on cash | - | - | -11 Thousand | - | - | - |
| Net cash flow / Change in cash | 1.98 Million | 7.38 Million | -32.62 Million | -6.3 Million | -8.29 Million | -3.64 Million |
| Free Cash Flow | -7.97 Million | -7.38 Million | -47.48 Million | -7.49 Million | -11.15 Million | -13.69 Million |
FAG
SNMSF
TIL
600071
VIPPYSP
LLD